Product Information

VYFEMLA 0.4 MG-0.035 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3182 per EA under NDC 68180087573. Its NADAC has been published 297 times since Mar 10, 2021.

FDA first approved this application on Sep 26, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VYFEMLA 0.4 MG-0.035 MG TABLET

norethindrone and ethinyl estradiol
$0.3182per EA

NDC

68180087573

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201886

FDA Approved

9/26/2013

TE Code

AB

On Market Since

11/4/2020

Price Statistics

The NADAC for VYFEMLA 0.4 MG-0.035 MG TABLET has been published 297 times since Mar 10, 2021, and over the history we have for it it has declined 32.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3182 per EA
All-time high$0.6417 (Oct 13, 2021)
All-time low$0.2566 (Nov 20, 2024)
52-week high$0.3471
52-week low$0.2982
Median price$0.4040
Average price$0.4194
Largest weekly change+55.5% (May 19, 2021)
Weeks tracked297
Tracking sinceMar 10, 2021

Price History

1W

0.0%

1M

-3.5%

3M

-1.4%

6M

+4.6%

1Y

-4.0%

3Y

-20.6%

5Y

-34.3%

All

-32.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VYFEMLA 0.4 MG-0.035 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VYFEMLA 0.4 MG-0.035 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3182 per EA (NDC 68180087573), effective Nov 11, 2026.

How has the price of VYFEMLA 0.4 MG-0.035 MG TABLET changed over time?

Over the history we have for it, the NADAC for VYFEMLA 0.4 MG-0.035 MG TABLET has declined 32.1%. It has been tracked across 297 weekly CMS publications since Mar 10, 2021.

What are the highest and lowest recorded NADAC prices for VYFEMLA 0.4 MG-0.035 MG TABLET?

Since Mar 10, 2021, the NADAC for VYFEMLA 0.4 MG-0.035 MG TABLET has ranged from a low of $0.2566 (Nov 20, 2024) to a high of $0.6417 (Oct 13, 2021), with a median of $0.4040 per EA.

Are there cheaper alternatives to VYFEMLA 0.4 MG-0.035 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYACEN 1-35 28 TABLET, is $0.1936 per EA — about 39% below VYFEMLA 0.4 MG-0.035 MG TABLET.

Who manufactures VYFEMLA 0.4 MG-0.035 MG TABLET?

VYFEMLA 0.4 MG-0.035 MG TABLET (NDC 68180087573) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.